These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11065280)

  • 1. Mechanisms of beta-amyloid neurotoxicity: perspectives of pharmacotherapy.
    Harkany T; Abrahám I; Kónya C; Nyakas C; Zarándi M; Penke B; Luiten PG
    Rev Neurosci; 2000; 11(4):329-82. PubMed ID: 11065280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity.
    Sturchler E; Galichet A; Weibel M; Leclerc E; Heizmann CW
    J Neurosci; 2008 May; 28(20):5149-58. PubMed ID: 18480271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease.
    Harkany T; Hortobágyi T; Sasvári M; Kónya C; Penke B; Luiten PG; Nyakas C
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):963-1008. PubMed ID: 10621945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands.
    Yao Z; Drieu K; Papadopoulos V
    Brain Res; 2001 Jan; 889(1-2):181-90. PubMed ID: 11166702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.
    Klein AN; Ziehm T; van Groen T; Kadish I; Elfgen A; Tusche M; Thomaier M; Reiss K; Brener O; Gremer L; Kutzsche J; Willbold D
    ACS Chem Neurosci; 2017 Sep; 8(9):1889-1900. PubMed ID: 28581708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
    Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
    Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,5,4'-trihydroxy-6,7,3'-trimethoxyflavone protects against beta amyloid-induced neurotoxicity through antioxidative activity and interference with cell signaling.
    Telerman A; Ofir R; Kashman Y; Elmann A
    BMC Complement Altern Med; 2017 Jun; 17(1):332. PubMed ID: 28645294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease.
    Kam TI; Gwon Y; Jung YK
    Cell Mol Life Sci; 2014 Dec; 71(24):4803-13. PubMed ID: 25151011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell degeneration induced by amyloid-beta peptides: implications for Alzheimer's disease.
    Pereira C; Ferreiro E; Cardoso SM; de Oliveira CR
    J Mol Neurosci; 2004; 23(1-2):97-104. PubMed ID: 15126695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
    Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
    Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease.
    Verdier Y; Zarándi M; Penke B
    J Pept Sci; 2004 May; 10(5):229-48. PubMed ID: 15160835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xylocoside G reduces amyloid-β induced neurotoxicity by inhibiting NF-κB signaling pathway in neuronal cells.
    Yu Y; Zhou L; Sun M; Zhou T; Zhong K; Wang H; Liu Y; Liu X; Xiao R; Ge J; Tu P; Fan DS; Lan Y; Hui C; Chui D
    J Alzheimers Dis; 2012; 30(2):263-75. PubMed ID: 22430528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notoginsenoside R1 attenuates amyloid-β-induced damage in neurons by inhibiting reactive oxygen species and modulating MAPK activation.
    Ma B; Meng X; Wang J; Sun J; Ren X; Qin M; Sun J; Sun G; Sun X
    Int Immunopharmacol; 2014 Sep; 22(1):151-9. PubMed ID: 24975829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pycnogenol protects neurons from amyloid-beta peptide-induced apoptosis.
    Peng QL; Buz'Zard AR; Lau BH
    Brain Res Mol Brain Res; 2002 Jul; 104(1):55-65. PubMed ID: 12117551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perlecan Domain V Inhibits Amyloid-β Induced Activation of the α2β1 Integrin-Mediated Neurotoxic Signaling Cascade.
    Parham CL; Shaw C; Auckland LD; Dickeson SK; Griswold-Prenner I; Bix G
    J Alzheimers Dis; 2016 Oct; 54(4):1629-1647. PubMed ID: 27636841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
    Aleksis R; Oleskovs F; Jaudzems K; Pahnke J; Biverstål H
    Biochimie; 2017 Sep; 140():176-192. PubMed ID: 28751216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
    De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
    FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.